Max Drawdown (5Y) Chart

Historical Max Drawdown (5Y) Data

View and export this data back to 2000. Start Trial.
Date Value
September 30, 2026 99.69%
August 31, 2026 99.69%
July 31, 2026 99.69%
June 30, 2026 99.69%
May 31, 2026 99.69%
April 30, 2026 99.69%
March 31, 2026 99.69%
February 28, 2026 99.69%
January 31, 2026 99.69%
December 31, 2025 99.69%
November 30, 2025 99.69%
October 31, 2025 99.69%
September 30, 2025 99.69%
August 31, 2025 99.69%
July 31, 2025 99.69%
June 30, 2025 99.85%
May 31, 2025 99.90%
April 30, 2025 99.94%
March 31, 2025 99.95%
February 28, 2025 99.95%
January 31, 2025 99.95%
December 31, 2024 99.95%
November 30, 2024 99.95%
October 31, 2024 99.95%
September 30, 2024 99.95%
Date Value
August 31, 2024 99.95%
July 31, 2024 99.95%
June 30, 2024 99.95%
May 31, 2024 99.95%
April 30, 2024 99.95%
March 31, 2024 99.95%
February 29, 2024 99.95%
January 31, 2024 99.95%
December 31, 2023 99.95%
November 30, 2023 99.95%
October 31, 2023 99.95%
September 30, 2023 99.95%
August 31, 2023 99.95%
July 31, 2023 99.95%
June 30, 2023 99.95%
May 31, 2023 99.95%
April 30, 2023 99.95%
March 31, 2023 99.95%
February 28, 2023 99.95%
January 31, 2023 99.95%
December 31, 2022 99.95%
November 30, 2022 99.95%
October 31, 2022 99.95%
September 30, 2022 99.95%
August 31, 2022 99.95%

Max Drawdown Definition

Max drawdown is an indicator of the risk of a portfolio chosen based on a certain strategy. It measures the largest single drop from peak to bottom in the value of a portfolio before a new peak is achieved.

Read full definition.

Max Drawdown (5Y) Range, Past 5 Years

View Max Drawdown (5Y) Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

Max Drawdown (5Y) Benchmarks

View Max Drawdown (5Y) Benchmarks
Start Trial
NeoGenomics, Inc. 91.92%
Quest Diagnostics, Inc. 28.60%
Labcorp Holdings, Inc. 34.60%
OPKO Health, Inc. 85.55%
Psychemedics Corp. 87.72%